morphine-6-glucuronide and Disease-Models--Animal

morphine-6-glucuronide has been researched along with Disease-Models--Animal* in 1 studies

Other Studies

1 other study(ies) available for morphine-6-glucuronide and Disease-Models--Animal

ArticleYear
Enhanced potency of intravenous, but not intrathecal, morphine and morphine-6-glucuronide after burn trauma.
    Life sciences, 1994, Volume: 54, Issue:22

    We examined the analgesic effect of morphine (M) and its metabolite morphine-6-glucuronide (M6G) in a rat model of acute thermal trauma. M or M6G were given by intrathecal (IT) or intravenous (i.v.) routes after brief burn or sham burn delivered during inhalational anesthesia. In the sham group, M6G was significantly less potent than M when given i.v., yet tended to be more potent than M when given IT. For both drugs, thermal injury increased i.v. potency, yet decreased (for M) or displayed a trend to decrease (for M6G) It potency. The increased potency seen with i.v. but not IT opioid administration may reflect pharmacokinetic (e.g., diminished clearance) and/or pharmacodynamic responses (e.g., activation of peripheral opioid receptors) after thermal injury.

    Topics: Analgesia; Animals; Burns; Disease Models, Animal; Dose-Response Relationship, Drug; Injections, Intravenous; Injections, Spinal; Male; Morphine; Morphine Derivatives; Rats; Rats, Sprague-Dawley

1994